ELV
Elevance Health · Health Care
2.6%
typical move (median |reaction| of last 8)
2026-10-20 pre · likely
next expected · estimated from pattern
12
scored events
Last eight reactions
2025-01-23 → 2026-07-15
| date | session | reaction | |move| | excess 5s | excess 20s |
|---|---|---|---|---|---|
| 2026-07-15 | pre | -9.5% | 9.5% | +0.8% | +0.1% |
| 2026-04-22 | pre | +0.0% | 0.0% | +14.8% | +16.5% |
| 2026-01-28 | pre | +5.8% | 5.8% | +0.9% | -4.7% |
| 2025-10-21 | pre | -1.2% | 1.2% | -5.4% | -5.7% |
| 2025-07-17 | pre | -11.8% | 11.8% | -8.7% | -5.4% |
| 2025-04-22 | pre | +2.1% | 2.1% | -5.7% | -13.3% |
| 2025-04-17 | pre | -2.3% | 2.3% | -5.3% | -17.9% |
| 2025-01-23 | pre | +2.8% | 2.8% | +0.2% | -2.6% |
Source filings
2026-07-15 · 8-K press release
E A R N I N G S R E L E A S E ELEVANCE HEALTH REPORTS SECOND QUARTER 2026 RESULTS; RAISES FULL-YEAR GUIDANCE • 2Q 2026 operating revenue of $49.8 billion, up 0.8% from 2Q 2025 • 2Q 2026 diluted EPS 1
2026-04-22 · 8-K press release
E A R N I N G S R E L E A S E ELEVANCE HEALTH REPORTS FIRST QUARTER 2026 RESULTS; RAISES FULL-YEAR GUIDANCE • 1Q 2026 operating revenue of $49.5 billion, up 1.5% from 1Q 2025 • 1Q 2026 diluted EPS 1 o
2026-01-28 · 8-K press release
E A R N I N G S R E L E A S E ELEVANCE HEALTH REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS; SETS FULL YEAR 2026 OUTLOOK • 4Q 2025 operating revenue of $49.3 billion; FY 2025 of $197.6 billion • 4
2025-10-21 · 8-K press release
E A R N I N G S R E L E A S E ELEVANCE HEALTH REPORTS THIRD QUARTER 2025 RESULTS • Executing with discipline to improve affordability and elevate the member experience • 3Q 2025 operating revenue of $
2025-07-17 · 8-K press release
E A R N I N G S R E L E A S E ELEVANCE HEALTH REPORTS SECOND QUARTER 2025 RESULTS • 2Q 2025 operating revenue of $49.4 billion, up 14.3% from 2Q 2024 • 2Q 2025 diluted EPS 1 of $7.72; adjusted diluted
2025-04-22 · 8-K press release
E A R N I N G S R E L E A S E ELEVANCE HEALTH REPORTS FIRST QUARTER 2025 RESULTS • 1Q 2025 operating revenue of $48.8 billion, up 15.4% from 1Q 2024 • 1Q 2025 adjusted operating gain 1 of $3.3 billion
2025-04-17 · 8-K press release
FALSE 0001156039 0001156039 2025-04-17 2025-04-17 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________ FORM 8-K _________________________________
2025-01-23 · 8-K press release
E A R N I N G S R E L E A S E ELEVANCE HEALTH REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS; SETS FULL YEAR 2025 OUTLOOK • 4Q 2024 operating revenue of $45.0 billion; FY 2024 of $175.2 billion • 4